{"id":"https://openalex.org/W2509748643","doi":"https://doi.org/10.3892/mco.2016.978","title":"Comparative safety of BRAF and MEK inhibitors (vemurafenib, dabrafenib and trametinib) in first-line therapy for BRAF-mutated metastatic melanoma","display_name":"Comparative safety of BRAF and MEK inhibitors (vemurafenib, dabrafenib and trametinib) in first-line therapy for BRAF-mutated metastatic melanoma","publication_year":2016,"publication_date":"2016-08-04","ids":{"openalex":"https://openalex.org/W2509748643","doi":"https://doi.org/10.3892/mco.2016.978","mag":"2509748643","pmid":"https://pubmed.ncbi.nlm.nih.gov/27699043","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5038159"},"language":"en","primary_location":{"id":"doi:10.3892/mco.2016.978","doi":"https://doi.org/10.3892/mco.2016.978","is_oa":true,"landing_page_url":"https://doi.org/10.3892/mco.2016.978","pdf_url":"http://www.spandidos-publications.com/mco/5/4/458/download","source":{"id":"https://openalex.org/S2754683124","display_name":"Molecular and Clinical Oncology","issn_l":"2049-9450","issn":["2049-9450","2049-9469"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320412","host_organization_name":"Spandidos Publishing","host_organization_lineage":["https://openalex.org/P4310320412"],"host_organization_lineage_names":["Spandidos Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular and Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"http://www.spandidos-publications.com/mco/5/4/458/download","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110591674","display_name":"Ana Cebollero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114530","display_name":"Hospital Universitario Miguel Servet","ror":"https://ror.org/01r13mt55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210114530"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ana Cebollero","raw_affiliation_strings":["Department of Medical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain","institution_ids":["https://openalex.org/I4210114530"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053722517","display_name":"Teresa Pu\u00e9rtolas","orcid":"https://orcid.org/0000-0003-3908-9199","observed_orcids":["https://orcid.org/0000-0003-3908-9199"]},"institutions":[{"id":"https://openalex.org/I4210114530","display_name":"Hospital Universitario Miguel Servet","ror":"https://ror.org/01r13mt55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210114530"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Teresa Pu\u00e9rtolas","raw_affiliation_strings":["Department of Medical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain","institution_ids":["https://openalex.org/I4210114530"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080923035","display_name":"Isabel Pajares","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114530","display_name":"Hospital Universitario Miguel Servet","ror":"https://ror.org/01r13mt55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210114530"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Isabel Pajares","raw_affiliation_strings":["Department of Medical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain","institution_ids":["https://openalex.org/I4210114530"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011493694","display_name":"Lourdes Calera","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114530","display_name":"Hospital Universitario Miguel Servet","ror":"https://ror.org/01r13mt55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210114530"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Lourdes Calera","raw_affiliation_strings":["Department of Medical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain","institution_ids":["https://openalex.org/I4210114530"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090790623","display_name":"Antonio Ant\u00f3n","orcid":"https://orcid.org/0000-0002-2802-6232","observed_orcids":["https://orcid.org/0000-0002-2802-6232"]},"institutions":[{"id":"https://openalex.org/I4210114530","display_name":"Hospital Universitario Miguel Servet","ror":"https://ror.org/01r13mt55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210114530"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Antonio Ant\u00f3n","raw_affiliation_strings":["Department of Medical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain","institution_ids":["https://openalex.org/I4210114530"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210114530"],"apc_list":null,"apc_paid":null,"fwci":1.6644,"has_fulltext":true,"cited_by_count":29,"citation_normalized_percentile":{"value":0.83745253,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":98},"biblio":{"volume":"5","issue":"4","first_page":"458","last_page":"462"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/braf-mutant-melanoma","display_name":"BRAF-mutant melanoma","score":0.8690000176429749},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/vemurafenib","display_name":"vemurafenib","score":0.9559999704360962},{"id":"https://openalex.org/keywords/dabrafenib","display_name":"dabrafenib","score":1.0},{"id":"https://openalex.org/keywords/trametinib","display_name":"trametinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.9399999976158142},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":1.0},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.6740000247955322},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8460000157356262},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.925000011920929},{"id":"https://openalex.org/keywords/real-world-safety","display_name":"real-world safety","score":0.4309999942779541}],"concepts":[{"id":"https://openalex.org/C2778830669","wikidata":"https://www.wikidata.org/wiki/Q3011604","display_name":"Dabrafenib","level":5,"score":0.9711283445358276},{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.9653627872467041},{"id":"https://openalex.org/C2778472372","wikidata":"https://www.wikidata.org/wiki/Q7833138","display_name":"Trametinib","level":4,"score":0.9584630727767944},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7059515714645386},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6132786273956299},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.5220329761505127},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5112662315368652},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4942333996295929},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.450860857963562},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44992223381996155},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.43846794962882996},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4302275478839874},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.3358737528324127},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12355154752731323},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3892/mco.2016.978","doi":"https://doi.org/10.3892/mco.2016.978","is_oa":true,"landing_page_url":"https://doi.org/10.3892/mco.2016.978","pdf_url":"http://www.spandidos-publications.com/mco/5/4/458/download","source":{"id":"https://openalex.org/S2754683124","display_name":"Molecular and Clinical Oncology","issn_l":"2049-9450","issn":["2049-9450","2049-9469"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320412","host_organization_name":"Spandidos Publishing","host_organization_lineage":["https://openalex.org/P4310320412"],"host_organization_lineage_names":["Spandidos Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular and Clinical Oncology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4005822","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5038159","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5038159","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5038159","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Clin Oncol","raw_type":"Text"},{"id":"pmid:27699043","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27699043","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular and clinical oncology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.3892/mco.2016.978","doi":"https://doi.org/10.3892/mco.2016.978","is_oa":true,"landing_page_url":"https://doi.org/10.3892/mco.2016.978","pdf_url":"http://www.spandidos-publications.com/mco/5/4/458/download","source":{"id":"https://openalex.org/S2754683124","display_name":"Molecular and Clinical Oncology","issn_l":"2049-9450","issn":["2049-9450","2049-9469"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320412","host_organization_name":"Spandidos Publishing","host_organization_lineage":["https://openalex.org/P4310320412"],"host_organization_lineage_names":["Spandidos Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular and Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2509748643.pdf","grobid_xml":"https://content.openalex.org/works/W2509748643.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W1828940258","https://openalex.org/W1842042263","https://openalex.org/W1879616740","https://openalex.org/W1908752382","https://openalex.org/W1917632054","https://openalex.org/W1951046932","https://openalex.org/W1964047953","https://openalex.org/W1965370740","https://openalex.org/W1986793246","https://openalex.org/W1989121777","https://openalex.org/W2017750556","https://openalex.org/W2019607817","https://openalex.org/W2097995306","https://openalex.org/W2099289479","https://openalex.org/W2105660237","https://openalex.org/W2116978375","https://openalex.org/W2118863192","https://openalex.org/W2120041024","https://openalex.org/W2123363005","https://openalex.org/W2126194543","https://openalex.org/W2128542677","https://openalex.org/W2131040858","https://openalex.org/W2136474966","https://openalex.org/W2163188200","https://openalex.org/W2164194457","https://openalex.org/W2166262263","https://openalex.org/W2203375835"],"related_works":["https://openalex.org/W2981669912","https://openalex.org/W2092383314","https://openalex.org/W2467048286","https://openalex.org/W2885410267","https://openalex.org/W3146911141","https://openalex.org/W1827097565","https://openalex.org/W3153310332","https://openalex.org/W2154748904","https://openalex.org/W4239202468","https://openalex.org/W2156078931"],"abstract_inverted_index":{"A":[0],"retrospective":[1],"observational":[2],"study":[3,56,124],"was":[4,57],"conducted":[5],"on":[6],"patients":[7],"diagnosed":[8],"with":[9,20],"serine/threonine-protein":[10],"kinase":[11,25,26],"B-Raf":[12],"(BRAF)-mutated":[13],"metastatic":[14],"melanoma,":[15],"who":[16],"underwent":[17],"first-line":[18],"therapy":[19],"BRAF":[21,64],"and":[22,36,49,65,83,91,98,100],"mitogen-activated":[23],"protein":[24],"(MEK)":[27],"inhibitors":[28],"(vemurafenib,":[29],"dabrafenib":[30,35,96,105],"or":[31],"a":[32],"combination":[33],"of":[34,54],"trametinib)":[37],"at":[38],"the":[39,60,86,95,104,122,127],"Miguel":[40],"Servet":[41],"University":[42],"Hospital":[43],"(Zaragoza,":[44],"Spain)":[45],"between":[46],"November,":[47],"2011":[48],"August,":[50],"2015.":[51],"The":[52,68],"aim":[53],"this":[55],"to":[58,74,135],"analyse":[59],"toxicity":[61],"produced":[62],"by":[63],"MEK":[66],"inhibitors.":[67],"most":[69],"common":[70],"toxicities":[71],"were":[72,118],"similar":[73,134],"those":[75,136],"published":[76],"in":[77,85,94,103,115,130,138],"clinical":[78,116,131,139],"trials,":[79],"particularly":[80],"arthralgia,":[81],"alopecia":[82],"photosensitivity":[84],"vemurafenib":[87],"group;":[88,97],"asthenia,":[89],"hyperkeratosis":[90],"dry":[92,101],"skin":[93,102],"diarrhoea":[99],"plus":[106],"trametinib":[107],"group.":[108],"Toxicities":[109],"that":[110,126],"had":[111],"not":[112],"been":[113],"described":[114],"trials":[117,132],"also":[119],"identified.":[120],"Thus,":[121],"present":[123],"confirmed":[125],"results":[128],"obtained":[129,137],"are":[133],"practice.":[140]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-09-16T00:00:00"}